Erectile Dysfunction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Erectile Dysfunction Devices Market by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, and Others), Approach (Invasive and Non-Invasive), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of erectile dysfunction and increase in geriatric population of men.

The erectile dysfunction devices market was valued at USD 1.78 billion in 2024, growing at a CAGR of 8.18% during the forecast period from 2025 to 2032 to reach USD 3.33 billion by 2032. The demand for erectile dysfunction (ED) devices is primarily driven by the rising prevalence of ED, particularly among men with chronic conditions such as cardiovascular disease (CVD), diabetes, and hypertension. ED is a common condition affecting men of all ages, but it is especially prevalent in older adults who often face underlying health issues like prostate cancer, anxiety, and depression. Additionally, the increasing geriatric male population, along with rising rates of obesity and sedentary lifestyle habits such as smoking and lack of physical activity, are key factors contributing to the market's growth. These trends are expected to fuel the positive expansion of the erectile dysfunction devices market during the forecast period from 2025 to 2032.

Erectile Dysfunction Devices Market Dynamics:

According to data from the World Health Organization (2022), an estimated 320 million people worldwide were expected to be affected by erectile dysfunction by 2025. A recent study published in Clinical Epidemiology & Global Health (2022) reported that more than 150 million men were affected by ED, with the number projected to reach 322 million by 2025. Erectile dysfunction devices are designed to restore penile function. Therefore, the growing prevalence of ED is a major factor driving market growth.

Additionally, several comorbidities, particularly cardiovascular diseases and diabetes, are significantly contributing to the increasing prevalence of ED. Studies have established a strong correlation between ED and heart conditions like hypertension and coronary artery disease. Since achieving an erection depends on adequate blood flow, impaired cardiac function can disrupt this process. According to WHO data (2023), in 2023, approximately 1.28 billion people aged 30-79 were living with hypertension globally. Reduced heart and arterial function disrupts blood flow in men, thereby contributing to erectile dysfunction and boosting the demand for treatment devices.

Diabetes, particularly type 2 diabetes mellitus (T2DM), is another key risk factor. Men with diabetes are three times more likely to develop ED compared to healthy individuals. As per the Centers for Disease Control and Prevention (CDC, 2024), this elevated risk is a significant concern. The International Diabetes Federation (2024), in 2021, over 537 million adults aged 20-79 were living with diabetes globally, with projections expected to rise to 643 million by 2030 and 783 million by 2045.

In addition to disease burden, demographic trends are also influencing market dynamics. The growing male population, especially aging men, is directly contributing to the rising incidence of erectile dysfunction. According to World Bank data (2022), the global male population increased from 4 billion in 2022 to 4.03 billion in 2023. As this population grows, so does the demand for effective ED treatment solutions, further accelerating the erectile dysfunction devices market.

Additionally, key players in the erectile dysfunction devices market are increasingly investing in research and development to introduce advanced treatment options. For instance, in September 2024, Haleon announced the launch of Eroxon®, the first and only FDA-cleared over-the-counter (OTC) gel for erectile dysfunction. Eroxon® had previously received MDR certification in Europe. Such innovative product launches are further fueling the growth of the erectile dysfunction devices market by expanding access to non-invasive and convenient treatment alternatives.

However, the high cost of advanced devices and complexity and chances of device malfunctioning, among others, are some of the key constraints that may limit the growth of the erectile dysfunction devices market.

Erectile Dysfunction Devices Market Segment Analysis:

Erectile Dysfunction Devices Market by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, and Others), Approach (Invasive and Non-Invasive), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the erectile dysfunction devices market, the vacuum therapy devices category is estimated to account for the largest market share in 2024. This growth is primarily driven by the increasing prevalence of erectile dysfunction among the global male population and the various advantages these devices offer in ED treatment. According to data from the Urology Foundation (2025), erectile dysfunction is prevalent in the UK, with approximately 4.3 million men affected. Similarly, the National Institute of Health (2024) reported that around 14 million men in Japan suffered from ED. The rising number of cases across different regions is significantly boosting demand for effective and accessible solutions like vacuum therapy devices.

Vacuum therapy devices provide several benefits that make them a popular treatment choice. These devices are noninvasive, easy to use, and capable of inducing an erection in as little as 2 to 3 minutes, offering increased spontaneity. Unlike surgical or pharmaceutical treatments, vacuum therapy devices do not require medication or invasive procedures, making them a reliable and appealing option for many men managing ED.

An example of such innovation is the Vacurect® Vacuum Erection Device by Vacurect, which features a compact, user-friendly design and a unique tension ring loading system to aid in effective ED treatment. As awareness and availability of such advanced solutions increase, the demand for vacuum therapy devices is expected to remain strong, reinforcing their dominance in the erectile dysfunction devices market.

Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of erectile dysfunction devices across the globe.

North America is expected to dominate the overall erectile dysfunction devices market:

North America is projected to hold the largest share of the erectile dysfunction devices market in 2024, driven by several key factors. This regional dominance is attributed to the growing prevalence of erectile dysfunction, along with increasing awareness among the population regarding the condition. Key factors such as product launches and approvals, as well as a rising number of individuals suffering from prostate cancer, hypertension, and diabetes in the region. These factors collectively contribute to the growth of the erectile dysfunction devices market in North America.

According to data from the Centers for Disease Control and Prevention (2024), approximately 30 million adults in the United States were affected by erectile dysfunction (ED) in 2021, with the condition being more prevalent among middle-aged and older men. This growing incidence of ED is driving the demand for erectile dysfunction devices, thereby contributing to market growth across the region.

One of the major contributing factors to ED in the U.S. is the increasing prevalence of prostate cancer. As reported by the American Cancer Society (2024), in 2024, over 299,010 prostate cancer cases were diagnosed in the United States, with an estimated 1.5 million men diagnosed each year. ED is a common side effect following prostate cancer treatments, including surgery and radiation therapy. As such, the growing burden of prostate cancer is expected to further fuel the demand for ED treatment devices.

Diabetes is another leading risk factor for erectile dysfunction. According to the American Heart Association (2024), in 2021, around 9.7 million adults in the U.S. were living with undiagnosed diabetes, while 29.3 million had been diagnosed. Additionally, 115.9 million Americans were reported to have prediabetes. Diabetes contributes to ED by damaging the blood vessels and nerves essential for normal erectile function. The increasing diabetic population is thus driving demand for effective ED devices, thereby driving the market growth.

Moreover, key market players in the region are focusing on technological advancements and product innovation. For example, in January 2025, Comphya SA, a pioneering medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval to initiate clinical trials for CaverSTIM, the first implantable neuromodulator developed to treat erectile dysfunction. Such advancements are expected to significantly propel the erectile dysfunction devices market in the region, offering new hope to millions of affected men.

Therefore, the combination of rising cases of erectile dysfunction, a high prevalence of risk factors such as hypertension, prostate cancer, diabetes, and others, and ongoing innovation in erectile dysfunction devices is expected to significantly propel the growth of the erectile dysfunction devices market in North America from 2025 to 2032.

Erectile Dysfunction Devices Market Key Players:

Some of the key market players operating in the erectile dysfunction devices market include Coloplast Group, Zimmer Aesthetics, Augusta Medical Systems, Medispec, MTS Medical, Boston Scientific Corporation, NOVAmedtek, Promedon GmbH, Global Life Technologies LLC, Zephyr Surgical Implants, Owen Mumford, Vacurect, T.E. Inc., SILIMED, STORZ MEDICAL AG, Rigicon, Inc., TIMM Medical, Alma Lasers, Comphya SA, Ohh-Med Medical Ltd., and others.

Recent Developmental Activities in the Erectile Dysfunction Devices Market:

• In June 2024, Ohh-Med Medical Ltd. launched VerticaPlus with a cloud-based mobile app. Vertica is a pioneering medical device designed to enhance erection quality over time by targeting the Tunica Albuginea in the penis, thereby reducing leakage and outflow. This innovative approach optimizes the natural erectile mechanism without relying on medication, allowing for complete spontaneity in intimate relations and eliminating associated side effects.
• In June 2023, Rigicon, Inc. launched the HL-LEVINE penile prosthesis tool. This prosthesis tool integrates the HL dilator with the traditional Furlow instrument, both of which are utilized in penile implant surgery. It streamlines the dilation and insertion process of penile implants, thereby reducing the risk of surgical complications and enhancing postoperative outcomes.

Key takeaways from the erectile dysfunction devices market report study

• Market size analysis for the current erectile dysfunction devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the erectile dysfunction devices market.
• Various opportunities available for the other competitors in the erectile dysfunction devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current erectile dysfunction devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the erectile dysfunction devices market growth in the future?

Target audience who can benefit from this erectile dysfunction device market report study

• Erectile dysfunction device product providers
• Research organizations and consulting companies
• Erectile dysfunction device-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in erectile dysfunction devices
• Various end-users who want to know more about the erectile dysfunction devices market and the latest technological developments in the erectile dysfunction devices market.

Frequently Asked Questions for the Erectile Dysfunction Devices Market:

1. What are erectile dysfunction devices?

• Erectile dysfunction devices refer to medical devices that pump blood through the penis for an erection to take place, allowing it to extend and stiffen, which is sparked by stimuli from the brain to the genital nerves. When these impulses are blocked or the supply of blood to the penis is reduced, Erectile Dysfunction Devices are used to treat the patient and restore normal functioning.

2. What is the market for erectile dysfunction devices?

• The erectile dysfunction devices market was valued at USD 1.78 billion in 2024, growing at a CAGR of 8.18% during the forecast period from 2025 to 2032 to reach USD 3.33 billion by 2032.

3. What are the drivers for the erectile dysfunction devices market?

• The demand for erectile dysfunction (ED) devices is primarily driven by the rising prevalence of ED, particularly among men with chronic conditions such as cardiovascular disease (CVD), diabetes, and hypertension. ED is a common condition affecting men of all ages, but it is especially prevalent in older adults who often face underlying health issues like prostate cancer, anxiety, and depression. Additionally, the increasing geriatric male population, along with rising rates of obesity and sedentary lifestyle habits such as smoking and lack of physical activity, are key factors contributing to the market's growth. These trends are expected to fuel the positive expansion of the erectile dysfunction devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the erectile dysfunction devices market?

• Some of the key market players operating in the erectile dysfunction devices market include Coloplast Group, Zimmer Aesthetics, Augusta Medical Systems, Medispec, MTS Medical, Boston Scientific Corporation, NOVAmedtek, Promedon GmbH, Global Life Technologies LLC, Zephyr Surgical Implants, Owen Mumford, Vacurect, T.E. Inc., SILIMED, STORZ MEDICAL AG, Rigicon, Inc., TIMM Medical, Alma Lasers, Comphya SA, Ohh-Med Medical Ltd., and others.

5. Which region has the highest share in the erectile dysfunction devices market?

• North America is projected to hold the largest share of the erectile dysfunction devices market in 2024, driven by several key factors. This regional dominance is attributed to the growing prevalence of erectile dysfunction, along with increasing awareness among the population regarding the condition. Key factors such as product launches and approvals, as well as a rising number of individuals suffering from prostate cancer, hypertension, and diabetes in the region. These factors collectively contribute to the growth of the erectile dysfunction devices market in North America.

This product will be delivered within 2 business days.